drugset
drugset / Trial / NCT01324310

Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

NCT01324310 ↗

Phase 1 Completed 15 enrolled Celgene Corporation
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to evaluate the effect and safety of multiple doses of ketoconazole on the pharmacokinetics of romidepsin after a single intravenous (IV) infusion.

Timeline

Start
2011-04-01
Primary completion
2012-01-01
Completion
2012-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 400 mg Oral
Subject Romidepsin Peptide 8 mg/m2 Intravenous

Indications

lymphoma